456
<i>PEPTOSTREPTOCOCCUS STOMATIS</i> PROMOTES COLORECTAL TUMORIGENESIS AND TYROSINE KINASE INHIBITOR RESISTANCE THROUGH ALTERNATIVE ACTIVATION OF ERBB2
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
<i>PEPTOSTREPTOCOCCUS ANEROBIUS </i>DIVES IMMUNE THERAPY RESISTANCE THROUGH MODULATING MDSCS IN COLORECTAL CANCER
BACKGROUND AND AIMS: Peptostreptococcus stomatis (_P. stomatis_) is an enriched bacterium in colorectal cancer (CRC) patients as compared to healthy subjects in multiple cohorts. However, the potential role of _P. stomatis_ in colorectal tumorigenesis remains obscure…
IMMUNE EVASION OF COLORECTAL CANCER STEM CELLS IS DEPENDENT ON SLC25A22-MEDIATED WNT SIGNALING
Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
<i>ROSEBURIA INTESTINALIS </i>GENERATED BUTYRATE BOOSTS ANTI-PD-1 EFFICACY IN COLORECTAL CANCER BY ACTIVATING CYTOTOXIC CD8<sup>+</sup> T CELLS
BACKGROUND: Emerging evidence suggest that gut microbiota influence human health such as digestive functions and risk of sepsis…
RNA N<sup>6</sup>-METHYLADENOSINE READER YTHDF1 PROMOTES STEMNESS AND DRUG RESISTANCE OF COLORECTAL CANCER THROUGH INDUCING NOTCH1 AND IS A THERAPEUTIC TARGET
BACKGROUND: Immune checkpoint blockade has revolutionized cancer treatment by harnessing the patient’s native anti-tumor T cells, but most colorectal cancers do not respond, for unclear reasons…